BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12187165)

  • 1. Assessing comorbidity using claims data: an overview.
    Klabunde CN; Warren JL; Legler JM
    Med Care; 2002 Aug; 40(8 Suppl):IV-26-35. PubMed ID: 12187165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
    Klabunde CN; Harlan LC; Warren JL
    Med Care; 2006 Oct; 44(10):921-8. PubMed ID: 17001263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources.
    Schrag D; Bach PB; Dahlman C; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-96-103. PubMed ID: 12187174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data.
    Wang PS; Walker A; Tsuang M; Orav EJ; Levin R; Avorn J
    J Clin Epidemiol; 2000 Jun; 53(6):571-8. PubMed ID: 10880775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement.
    Baldwin LM; Adamache W; Klabunde CN; Kenward K; Dahlman C; L Warren J
    Med Care; 2002 Aug; 40(8 Suppl):IV-82-95. PubMed ID: 12187173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
    Warren JL; Klabunde CN; Schrag D; Bach PB; Riley GF
    Med Care; 2002 Aug; 40(8 Suppl):IV-3-18. PubMed ID: 12187163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological issues in the use of administrative claims data to study surveillance after cancer treatment.
    Butler Nattinger A; Schapira MM; Warren JL; Earle CC
    Med Care; 2002 Aug; 40(8 Suppl):IV-69-74. PubMed ID: 12187171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administrative and claims records as sources of health care cost data.
    Riley GF
    Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the SEER-Medicare data to identify chemotherapy use.
    Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
    Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Cancer-Directed Surgeries in Medicare Claims: A Validation Study Using SEER-Medicare Data.
    Lavery JA; Lipitz-Snyderman A; Li DG; Bach PB; Panageas KS
    JCO Clin Cancer Inform; 2019 Feb; 3():1-24. PubMed ID: 30715928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations.
    Bach PB; Guadagnoli E; Schrag D; Schussler N; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-19-25. PubMed ID: 12187164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
    Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
    J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.